FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.92
+1.03%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+31.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 25, 2026 | PARSHALL B LYNNE · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | SMITH IAN F · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Mendelsohn Michael · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Gallagher Neil · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Biller Scott · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Duty Stuart · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Lynch Thomas J. Jr. · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | Cole Douglas G. · director | A-Award | 28,000 | $4.08 |
| Jun 25, 2026 | GILL SIMBA · director | A-Award | 28,000 | $4.08 |
| Feb 24, 2026 | Maynard Ryan D · officer: Chief Financial Officer | A-Award | 400,000 | $5.75 |
| Feb 6, 2026 | GOTTSCHALK ADRIAN · director, officer: Chief Executive Officer | A-Award | 1,075,000 | $5.23 |
| Feb 2, 2026 | Bellon Steven F. · officer: Chief Scientific Officer | A-Award | 300,000 | $5.71 |
| Feb 2, 2026 | LaCascia Michael · officer: Chief Legal Officer | A-Award | 295,000 | $5.71 |
| Feb 2, 2026 | Costa Carlos · officer: Chief People Officer | A-Award | 230,000 | $5.71 |
| Feb 2, 2026 | Cardama Alfonso Quintas · officer: Chief Medical Officer | A-Award | 300,000 | $5.71 |
| Feb 2, 2026 | Rivkin Anna · officer: Chief Business Officer | A-Award | 165,000 | $5.71 |
| Jan 15, 2026 | Flagship Pioneering, LLC · director, 10 percent owner: | A-Award | 1,117,734 | $13 |
| Jan 15, 2026 | Flagship Pioneering, LLC · director, 10 percent owner: | A-Award | 2,235,468 | $0.00 |
| Jun 17, 2025 | SMITH IAN F · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | PARSHALL B LYNNE · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | Mendelsohn Michael · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | Lynch Thomas J. Jr. · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | GILL SIMBA · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | Biller Scott · director | A-Award | 25,000 | $4.79 |
| Jun 17, 2025 | Cole Douglas G. · director | A-Award | 25,000 | $4.79 |
| May 2, 2025 | Duty Stuart · director | A-Award | 50,000 | $4.16 |
| May 2, 2025 | Gallagher Neil · director | A-Award | 50,000 | $4.16 |
| Jan 24, 2025 | LaCascia Michael · officer: Chief Legal Officer | A-Award | 126,000 | $4.37 |
| Jan 24, 2025 | GOTTSCHALK ADRIAN · director, officer: Chief Executive Officer | A-Award | 400,000 | $4.37 |
| Jan 24, 2025 | Bellon Steven F. · officer: Chief Scientific Officer | A-Award | 140,000 | $4.37 |
Institutional positioning
13F filings over the trailing two quarters
New 22Increased 40Reduced 23Sold out 101
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FLAGSHIP PIONEERING INC. | Unchanged | 12,674,120 | May 15, 2026 |
| FMR LLC | Increased | 6,047,198 | May 15, 2026 |
| BVF INC/IL | Increased | 5,842,000 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 4,394,367 | May 15, 2026 |
| RAYMOND JAMES FINANCIAL INC | Increased | 2,602,382 | May 14, 2026 |
| BLACKROCK, INC. | Increased | 2,364,866 | May 13, 2026 |
| EUCLIDEAN CAPITAL LLC | Unchanged | 1,573,761 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,495,089 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 848,172 | May 15, 2026 |
| SIREN, L.L.C. | Unchanged | 720,720 | May 14, 2026 |
| STATE STREET CORP | Increased | 679,787 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 448,976 | Jul 17, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 406,425 | May 14, 2026 |
| CANDRIAM S.C.A. | New Position | 313,765 | Apr 30, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Increased | 303,757 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 25, 2026